Cardiol Therapeutics (CRDL) Insider Trading & Ownership C$1.95 +0.04 (+2.09%) As of 03:59 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock Cardiol Therapeutics (TSE:CRDL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.57%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)C$299.95KNumber OfInsiders Selling(Last 12 Months)0 Get CRDL Insider Trade Alerts Want to know when executives and insiders are buying or selling Cardiol Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRDL Insider Buying and Selling by Quarter Cardiol Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/26/2024Guillermo TorreSenior OfficerBuy17,240C$1.81C$31,277.7712/19/2024Andrew Warwick HamerSenior OfficerBuy18,900C$1.88C$35,606.6912/17/2024Bernard LimSenior OfficerBuy10,000C$1.95C$19,500.0012/16/2024David ElsleyDirectorBuy40,000C$1.88C$75,072.006/24/2024David ElsleyDirectorBuy50,000C$2.77C$138,490.00 (Data available from 1/1/2013 forward) CRDL Insider Trading Activity - Frequently Asked Questions Who is on Cardiol Therapeutics's Insider Roster? The list of insiders at Cardiol Therapeutics includes Andrew Warwick Hamer, Bernard Lim, David Elsley, and Guillermo Torre. Learn more on insiders at CRDL. What percentage of Cardiol Therapeutics stock is owned by insiders? 4.57% of Cardiol Therapeutics stock is owned by insiders. Learn more on CRDL's insider holdings. Which Cardiol Therapeutics insiders have been buying company stock? The following insiders have purchased CRDL shares in the last 24 months: Andrew Warwick Hamer (C$35,606.69), Bernard Lim (C$19,500.00), David Elsley (C$213,562.00), and Guillermo Torre (C$31,277.77). How much insider buying is happening at Cardiol Therapeutics? Insiders have purchased a total of 136,140 CRDL shares in the last 24 months for a total of C$299,946.47 bought. Cardiol Therapeutics Key ExecutivesMr. David G. Elsley MBAPresident, CEO & DirectorMr. Christopher J. Waddick C.A.C.M.A., CPA, CMA, MBA, CFO, Corporate Secretary & DirectorMr. Bernard Lim B.Sc.Chief Operating OfficerDr. Andrew Warwick Hamer M.D. (Age 62)Chief Medical Officer & Head of Research & Development Compensation: $746.56k1 recent tradesTrevor BurnsInvestor Relations More Insider Trading Tools from MarketBeat Related Companies FRX Insider Transactions APM Insider Transactions GXE Insider Transactions MDNA Insider Transactions CGC Insider Transactions RGC Insider Transactions ASND Insider Transactions GRI Insider Transactions NBY Insider Transactions PBM Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (TSE:CRDL) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
